SARS-CoV-2 mRNA vaccine is re-adenylated in vivo, enhancing antigen production and immune response
P. S. Krawczyk, O. Gewartowska, M. Mazur, W. Orzel, K. Matylla-Kulinska, S. Jelen, P. Turowski, T. Spiewla, B. Tarkowski, A. Tudek, A. Brouze, A. Wesolowska, D. Nowis, J. Golab, J. Kowalska, , S. Mroczek
This study shows that SARS-CoV-2 mRNA vaccines are re-adenylated in vivo, increasing antigen production and immune response in macrophages.
bioRxiv · Dec 1, 2022 · PreprintImmunology